How RWE can support drug development during COVID-19 and beyond
The COVID-19 pandemic introduced novel challenges for global biopharma organizations, as many...
The COVID-19 pandemic introduced novel challenges for global biopharma organizations, as many...
COVID-19 has heightened the need for an expanded understanding of clinical trial populations and...
Capturing the true complexity of psoriasis in the real world Psoriasis is a common chronic inflammatory disease affecting roughly 2-3% of U.S. adults (over 7.5 million people) making it one of the most prevalent immune-mediated conditions in the coun...